Amplified fragment length polymorphism analysis of human clinical isolates of Mycobacterium haemophilum from different continents

Clinical Microbiology and Infection

Volumn 15, Issue 10, 2009, Pages 924-930

  Bruijnesteijn van Coppenraet, L E S ^a   Savelkoul, P H M ^b   Buffing, N ^b   van der Bijl, M W ^b   Woudenberg, J ^b   Lindeboom, J A ^c   Kiehn, T E ^d   Haverkort, F ^e   Samra, Z ^f   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Western Australian Centre for Pathology and Medical Research   (Australia)

^f RABIN MEDICAL CENTER   (Israel)

Author keywords

AFLP; DICE; Genotype; Lymphadenitis; Mycobacterium haemophilum; Opportunistic pathogen

Indexed keywords

RESTRICTION ENDONUCLEASE;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; AUSTRALIA; BACTERIUM ISOLATE; CLUSTER ANALYSIS; CONTROLLED STUDY; EUROPE; GENETIC STABILITY; GENETIC VARIABILITY; GEOGRAPHIC ORIGIN; ISRAEL; MYCOBACTERIUM HAEMOPHILUM; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE; UNITED STATES;

MYCOBACTERIUM HAEMOPHILUM;

EID: 70350583065     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02798.x     Document Type: Article

References (24)

1. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. Mycobacterium haemophilum sp. nov. a new pathogen of humans. Int J Syst Bacteriol 1978, 28:67-75.
2. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996, 9:435-447.
3. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001, 33:330-337.
4. Bruijnesteijn van Coppenraet LES, Kuiper EJ, Lindeboom JA, Prins JM, Claas ECJ. Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005, 11:62-68.
5. Lindeboom JA, Prins JM, Bruijnesteijn van Coppenraet LES, Lindeboom R, Kuiper EJ. Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis 2005, 41:1569-1575.
6. Falkinham JO, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 2001, 67:1225-1231.
7. Smith S, Taylo GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis 2003, 37:e100-e101.
8. Whipps CM, Scott TD, Kent ML. Mycobacterium haemophilum infections of zebrafish (Danio rerio) in research facilities. FEMS Microbiol Lett 2007, 270:21-26.
9. Haverkort F. Australian mycobacterium reference laboratory network; special interest group in mycobacteria within the Australian Society for Microbiology. National Atypical Mycobacteria Survey. Commun Dis Intell 2003, 27:180-189.
10. Samra Z, Kaufmann L, Zeharia A. Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol 1999, 37:832-834.
11. Mycobacterium haemophilum infections - New York City metropolitan area, 1990-1991. MMWR Morb Mortal Wkly Rep 1991, 40:637-643.
12. Kikuchi K, Bernard EM, Kiehn TE, Armstrong D, Riley LW. Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol 1994, 32:1763-1767.
13. Yakrus MA, Straus WL. DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis. J Clin Microbiol 1994, 32:1083-1084.
14. Gürtler V, Mayall BC. Genomic approaches to typing, taxonomy and evolution of bacterial isolates. Int J Syst Evol Microbiol 2001, 51:3-16.
15. Pfaller SL, Aronson TW, Holtzman AE, Covert TC. Amplified fragment length polymorphism analysis of Mycobacterium avium complex isolates recovered from southern California. J Med Microbiol 2007, 56:1152-1160.
16. Picardeau M, Prod'Hom G, Raskine L, LePennec MP, Vincent V. Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997, 32:25-32.
17. Devulder G, Perouse de Montclos M, Flandrois JP. A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int J Syst Evol Microbiol 2005, 55:293-302.
18. Mohamed AM, Wen PC, Tarantolo S, Hinrichs SH. Mycobacterium nebraskense sp. nov., a novel slowly growing scotochromogenic species. Int J Syst Evol Microbiol 2004, 54:2057-2060.
19. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003, 16:319-354.
20. Bottger EC, Teske A, Kirschner P. Disseminated 'Mycobacterium genavense' infection in patients with AIDS. Lancet 1992, 11:76-80.
21. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990, 28:495-503.
22. van Belkum A, Tassios PT, Dijkshoorn L. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM). Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007, 13(suppl 3):1-46.
23. White DA, Kiehn TE, Bondoc AY, Massarella SA. Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med 1999, 160:1366-1368.
24. von Reyn CF, Maslow JN, Barber TW, Falkinham JO, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994, 7:1137-1141.